| Stereochemistry | RACEMIC |
| Molecular Formula | C11H13FN2 |
| Molecular Weight | 192.2327 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N)CC1=CNC2=C1C=C(F)C=C2
InChI
InChIKey=CTGFDWBZMCPVED-UHFFFAOYSA-N
InChI=1S/C11H13FN2/c1-7(13)4-8-6-14-11-3-2-9(12)5-10(8)11/h2-3,5-7,14H,4,13H2,1H3
| Molecular Formula | C11H13FN2 |
| Molecular Weight | 192.2327 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
|
|
TARGET -> INHIBITOR |
Strong inhibitor. As can be seen, 5-FMT dose-dependently inhibited only the activity of MAO A similarly in these regions of the brain with no effect on MAOB. The IC50 values (the dose to inhibit MAO A activity 50%) in these regions of the brain were about 11 mg/kg (0.05 mmol/kg).
|
||
|
|
TARGET -> AGONIST |
Could be an active psychedelic in humans, although it is not known to have been tested in humans and could be dangerous due to its strong inhibition of MAO-A.
|
Showing 1 to 2 of 2 entries
